Current status of sentinel lymph node biopsy in early breast cancer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


In patients with primary breast cancer, the sentinel lymph node biopsy (SLNB) is a minimally invasive method of assessing nodal status, with the aim of reducing the morbidity of axillary lymph node dissection (ALND). The SLNB technique is relatively new, and there are several ongoing clinical trials to assess its long-term effects on survival, local recurrence, and morbidity. Yet, surgeons throughout the United States have already adopted it into their practices, and it is now widely used in the management of patients with primary breast cancer. In this article, we discuss some of the pertinent issues pertaining to the application of SLNB in the management of breast cancer.

Original languageEnglish (US)
Pages (from-to)215-221
Number of pages7
JournalInternational Journal of Fertility and Women's Medicine
Issue number5
StatePublished - Sep 1 2004
Externally publishedYes


  • Adjuvant therapy
  • Axillary lymph node dissection
  • Clinical trials
  • Survival

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology


Dive into the research topics of 'Current status of sentinel lymph node biopsy in early breast cancer'. Together they form a unique fingerprint.

Cite this